Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.
Source: CNBC Top. Read the original report: https://www.cnbc.com/2026/09/14/novo-nordisk-rebrands-to-novo-ceo-mike-doustdar.html
Related stories
Why is JD Vance Campaigning in Kansas, a Red State?
Why is JD Vance campaigning in a red state?
Emmy Awards Live Updates: Television’s Biggest Stars Gather on the Red Carpet
Mariska Hargitay will host the ceremony in Los Angeles, where Jean Smart and Matthew Rhys will chase milestones, and Apple TV hopes to lead in awards for the first time.
Madueke a target for Euro loans - Tuesday's gossip
Atletico Madrid and Juventus track Noni Madueke, Liverpool are among the clubs looking at PSV's Paul Wanner, Lazio consider free agent Mauro Icardi, plus more.
Gavin Newsom Says He Won’t Run in 2028 if Kamala Harris Does
The comments made to CNN, if taken at face value, seemed to fly in the face of the California governor’s presidential ambitions.